Skip to content
GenoLensGenoLens

LFNG

Chr 7p22.3

LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase

Aliases:
SCDO3
MANE:
ENST00000222725.10

Annotations refreshed 1 month ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Congenital disorders of glycosylation

    BIALLELIC, autosomal or pseudoautosomal
  • DDG2P

    BIALLELIC, autosomal or pseudoautosomal
  • Fetal anomalies

    BIALLELIC, autosomal or pseudoautosomal
  • Likely inborn error of metabolism

    BIALLELIC, autosomal or pseudoautosomal
  • Skeletal dysplasia

    BIALLELIC, autosomal or pseudoautosomal
  • Familial Neural Tube Defects

    BIALLELIC, autosomal or pseudoautosomal
  • Intellectual disability

    BIALLELIC, autosomal or pseudoautosomal
  • Monogenic hearing loss

+1 more panels — install the extension to see the full list inline on any page.

Disease associations (Open Targets)

  • autosomal recessive spondylocostal dysostosis

    0.76
  • hypertensive disorder

    0.49
  • cardiovascular disorder

    0.42
  • spondylocostal dysostosis

    0.37
  • neurodegenerative disease

    0.37
  • Increased blood pressure

    0.32
  • benign prostatic hyperplasia

    0.30
  • cardiac arrest

    0.28
  • heart conduction disease

    0.28
  • essential hypertension

    0.27

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe

Glycosyltransferase that initiates the elongation of O-linked fucose residues attached to EGF-like repeats in the extracellular domain of Notch molecules. Modulates NOTCH1 activity by modifying O-fucose residues at specific EGF-like domains resulting in inhibition of NOTCH1 activation by JAG1 and enhancement of NOTCH1 activation by DLL1 via an increase in its binding to DLL1 (By similarity). Decreases the binding of JAG1 to NOTCH2 but not that of DLL1 (PubMed:11346656). Essential mediator of somite segmentation and patterning (By similarity)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.